Levamisole treatment for children with steroid sensitive nephrotic syndrome. A multi-centre, double-blind, placebo-controlled, randomised trial
Phase of Trial: Phase III
Latest Information Update: 15 Dec 2016
At a glance
- Drugs Levamisole (Primary)
- Indications Nephrotic syndrome
- Focus Registrational; Therapeutic Use
- Sponsors Ace Pharmaceuticals
- 19 Dec 2013 According to an Ace Pharmaceuticals media release, Professor Jean Claude Davin and pediatrician Mariken Gruppen of the AMC (Academic Medical Center, Amsterdam) were acting as principal investigator (JCD) and study coordinator.
- 19 Dec 2013 According to an Ace Pharmaceuticals media release, database lock date of this study was 19th December 2013.